| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
8,608,597 | 8,665,677 | 8,252,664 | 7,910,870 | 8,420,080 |
| Cost of Revenue
|
-5,307,476 | -5,287,796 | -4,997,281 | -4,713,060 | -4,629,698 |
|
Gross Profit
|
3,301,121 | 3,377,881 | 3,255,383 | 3,197,810 | 3,790,382 |
| Selling, General and Administrative Expenses
|
-648,421 | -611,977 | -600,803 | -592,750 | -637,905 |
|
Research and Development Expenses
|
-1,147,365 | -1,088,330 | -1,067,566 | -1,019,810 | -1,040,774 |
|
Operating Income/Expenses
|
-1,795,786 | -1,700,307 | -1,668,369 | -1,612,560 | -1,678,679 |
|
Total Operating Profit/Loss
|
1,505,335 | 1,677,574 | 1,587,014 | 1,585,250 | 2,111,703 |
| Total Net Finance Income/Expense
|
75,556 | 77,574 | 62,960 | 86,777 | 19,997 |
| Net Investment Income
|
-7,524 | -7,446 | -3,197 | -2,329 | 416 |
| Irregular Income/Expenses
|
-181 | -578 | -573 | 0 | 1,888 |
|
Other Income/Expense, Non-Operating
|
250,273 | 39,908 | 183,433 | 115,701 | 246,890 |
|
Non-Operating Income/Expenses, Total
|
318,124 | 109,458 | 242,623 | 200,149 | 269,191 |
|
Pretax Income
|
1,823,459 | 1,787,032 | 1,829,637 | 1,785,399 | 2,380,894 |
|
Provision for Income Tax
|
-207,064 | -236,287 | -252,880 | -299,450 | -408,135 |
|
Net Income from Continuing Operations
|
1,616,395 | 1,550,745 | 1,576,757 | 1,485,949 | 1,972,759 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,616,395 | 1,550,745 | 1,576,757 | 1,485,949 | 1,972,759 |
|
Non-Controlling/Minority Interests
|
-40,900 | -28,014 | -41,477 | 124 | -47,197 |
|
Net Income after Non-Controlling/Minority Interests
|
1,575,495 | 1,522,731 | 1,535,280 | 1,486,073 | 1,925,562 |
|
Net Income Available to Common Stockholders
|
1,575,495 | 1,522,731 | 1,535,280 | 1,486,073 | 1,925,562 |
|
Diluted Net Income Available to Common Stockholders
|
1,575,495 | 1,522,731 | 1,535,280 | 1,486,073 | 1,925,562 |
| Basic EPS
|
18.38 | 17.76 | 17.91 | 17.33 | 22.46 |
| Diluted EPS
|
18.36 | 17.74 | 17.89 | 17.26 | 21.89 |
|
Basic Weighted Average Shares Outstanding
|
85,719.58 | 85,739.36 | 85,721.94 | 85,751.47 | 85,732.95 |
|
Diluted Weighted Average Shares Outstanding
|
85,812.79 | 85,836.02 | 85,817.78 | 86,099.25 | 87,965.37 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,747,903 | 1,709,458 | 1,766,677 | 1,698,622 | 2,360,897 |
|
EBITDA
|
1,884,072 | 1,844,727 | 1,908,617 | 1,838,724 | 2,500,579 |
|
Normalized EBITDA
|
1,883,021 | 1,847,136 | 1,907,892 | 1,840,160 | 2,490,086 |
|
Normalized Income
|
1,615,463.35 | 1,552,835.47 | 1,576,132.20 | 1,487,144.15 | 1,964,064.72 |
|
Total Unusual Items
|
-1,051 | 2,409 | -725 | 1,436 | -10,493 |
12/31/2022 - 12/30/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade